Boothbay Fund Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
+89,763
New +$1.19M 0.02% 849
2025
Q1
– Sell
-120,589
Closed -$5.37M – 1706
2024
Q4
$5.37M Buy
120,589
+82,513
+217% +$3.38M 0.13% 227
2024
Q3
$1.74M Buy
+38,076
New +$1.54M 0.04% 568
2024
Q2
– Sell
-6,435
Closed -$308K – 1800
2024
Q1
$308K Buy
+6,435
New +$375K 0.01% 1181
2022
Q3
– Sell
-61,036
Closed -$5.93M – 2538
2022
Q2
$5.93M Buy
61,036
+36,536
+149% +$3.72M 0.16% 137
2022
Q1
$2.75M Buy
24,500
+22,508
+1,130% +$2.4M 0.06% 437
2021
Q4
$269K Buy
+1,992
New +$277K 0.01% 1316
2021
Q3
– Sell
-1,652
Closed -$212K – 2128
2021
Q2
$212K Buy
+1,652
New +$194K 0.01% 1488
2021
Q1
– Sell
-2,721
Closed -$489K – 1746
2020
Q4
$489K Buy
+2,721
New +$605K 0.02% 752
2016
Q1
– Sell
-12,959
Closed -$275K – 726
2015
Q4
$275K Buy
+12,959
New +$263K 0.12% 301

Other funds holding QDEL

Boothbay Fund Management's QDEL Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in QuidelOrtho (QDEL) in Q2 2026: 89,763 shares worth $1.57M. The stake represents 0.02% of the portfolio and ranks #849 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in QDEL as recently as Q4 2024.

Boothbay Fund Management first reported a position in QDEL in Q4 2015 and has held it in 10 quarters since. The position peaked at $5.93M in Q2 2022. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • Boothbay Fund Management held 89,763 shares of QuidelOrtho worth $1.57M as of Q2 2026.
  • QuidelOrtho was a new Boothbay Fund Management position in Q2 2026.
  • QuidelOrtho made up 0.02% of Boothbay Fund Management's portfolio in Q2 2026, its #849 holding.
  • Boothbay Fund Management first reported a position in QuidelOrtho in Q4 2015 and has held it in 10 quarters since.
  • Boothbay Fund Management's QuidelOrtho position peaked at $5.93M in Q2 2022.
  • 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.